Vital Transformation Study - H.R. 3 and Reference Pricing: - Total Market Impact on California’s Innovation Ecosystem

3 and Reference Pricing: Total Market Impact on California’s Innovation Ecosystem The study, released in March 2021 by the international health economics firm Vital Transformation, assesses the impact of price setting, as proposed by H. [...] 3 and Reference Pricing: Total Market Impact on California’s Innovation Ecosystem Impact on California’s innovation ecosystem California’s biopharmaceutical sector is the largest in the U. [...] over the last 10 years, only California biotechnology companies produced 16 of the two of the 16 medicines 68 drugs developed over the last 10 years with venture produced in California from venture partnerships would If H. [...] 3 had been in place over the last 10 years, only two of the 16 medicines produced in California from have come to market – an venture partnerships would have come to market – an 88% 88% reduction reduction. [...] 3 was statistically modeled to determine the revised probability of approved products entering the market from 2009-2019.